about
A survey on "Trojan Horse" peptides: opportunities, issues and controlled entry to "Troy".Dosage Form Developments of Nanosuspension Drug Delivery System for Oral Administration Route.Design, fabrication and biomedical applications of zein-based nano/micro-carrier systems.In-vitro cytotoxicity, in-vivo biodistribution and anti-tumour effect of PEGylated liposomal topotecan.Self-micellizing solid dispersions enhance the properties and therapeutic potential of fenofibrate: Advantages, profiles and mechanisms.A novel disulfide-stabilized single-chain variable antibody fragment against rabies virus G protein with enhanced in vivo neutralizing potency.Conformational and bioactivity analysis of insulin: freeze-drying TBA/water co-solvent system in the presence of surfactant and sugar.Size-controlled fabrication of zein nano/microparticles by modified anti-solvent precipitation with/without sodium caseinate.Synthesis, Characterization and In Vitro Evaluation of a Novel Glycol Chitosan-EDTA Conjugate to Inhibit Aminopeptidase-Mediated Degradation of Thymopoietin Oligopeptides.Intelligent "Peptide-Gathering Mechanical Arm" Tames Wild "Trojan-Horse" Peptides for the Controlled Delivery of Cancer Nanotherapeutics.On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology.An Investigation into the Gastrointestinal Stability of Exenatide in the Presence of Pure Enzymes, Everted Intestinal Rings and Intestinal Homogenates.Degradation kinetics of fluorouracil-acetic-acid-dextran conjugate in aqueous solution.Deepened cellular/subcellular interface penetration and enhanced antitumor efficacy of cyclic peptidic ligand-decorated accelerating active targeted nanomedicinesThe Influence of Cellulosic Polymer's Variables on Dissolution/Solubility of Amorphous Felodipine and Crystallization Inhibition from a Supersaturated StateHot melt extrusion technology for improved dissolution, solubility and "spring-parachute" processes of amorphous self-micellizing solid dispersions containing BCS II drugs indomethacin and fenofibrate: Profiles and mechanismsThe Effect of Size, Dose, and Administration Route on Zein Nanoparticle Immunogenicity in BALB/c Mice
P50
Q38242733-A75B7B4F-1D15-4541-B952-1EE388FA57A0Q38577359-8CB4E510-D721-42AB-8BC2-5B5BD9378F14Q38951315-5413E93B-2047-4A6B-89C5-8A512FB5879FQ40356343-F97B07BF-422A-4A5B-82CD-C7B2E1D1A8B5Q42698967-08B653D7-3CC1-4FE6-9934-17BA8B60D5D7Q45358515-85B19966-BCAE-491A-A106-6ED27633504CQ46168012-043F6BC5-793E-403E-AA95-E5F50D133295Q47152873-8E6C849B-B605-43E8-B4D1-254B6AC1A918Q47652321-146DF56F-4902-41FA-ADA7-93E891821271Q48262169-E795856D-27BB-411F-8544-675C6845B6D3Q51105115-8A1D360D-F47C-483F-82E8-2C77C2F41CDFQ51578715-F3640EE7-5E6F-4922-A699-8C08B2580E33Q51936193-CEDFA5C8-56F8-47A0-9BB8-C081F286CBFBQ57073301-C08286FE-C1EE-47EB-ADBB-CC1C8F49130BQ90601897-F8913033-7B63-494E-B999-F11963B8235EQ91233888-06E3E4A1-F818-4461-972D-3EB96A30232FQ92460885-14FA7899-CF5E-485F-A121-E8627A47EF3A
P50
description
researcher
@en
հետազոտող
@hy
name
Yong Zhang
@ast
Yong Zhang
@en
Yong Zhang
@es
Yong Zhang
@nl
Yong Zhang
@sl
type
label
Yong Zhang
@ast
Yong Zhang
@en
Yong Zhang
@es
Yong Zhang
@nl
Yong Zhang
@sl
prefLabel
Yong Zhang
@ast
Yong Zhang
@en
Yong Zhang
@es
Yong Zhang
@nl
Yong Zhang
@sl
P1053
H-2552-2013
P106
P108
P1153
25959477700
P31
P3829
P3835
yong-zhang45
P496
0000-0001-6577-5235